JANSSEN-CILAG, S.A. secures contract for Various medicinal products - Supply of the medication whose Active Ingredient is DARATUMUMAB for the Salamanca University Care Complex

Spain, March 6 -- Spain based JANSSEN-CILAG, S.A. has secured contract from Gerencia de Atencion Especializada de Salamanca for Various medicinal products - Supply of the medication whose Active Ingredient is DARATUMUMAB for the Salamanca University Care Complex. The value of the contract is worth 181579214 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....